How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

What it is about

Who published it, and when

How it spread - 73 original reports, 3 reprints

1. Wed, 5 August 2026

   1 report
   • Google News - Europe query16:52first to report
     How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

     How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? MarketWatch

2. Thu, 6 August 2026

   2 reports
   • Google News - Top Stories13:45
     The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

     The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings CNBC Lilly climbs, Novo falls as obesity drug battle intensifies BioPharma Dive How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? MarketWatch Lilly confident in slow and steady Foundayo launch, as ex-US sales shine BioSpace Lilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom Fierce Pharma

   • Google News - Top Stories13:45
     The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

     The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings CNBC Lilly climbs, Novo falls as obesity drug battle intensifies BioPharma Dive Lilly confident in slow and steady Foundayo launch, as ex-US sales shine BioSpace How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? MarketWatch Novo takes another shot at Lilly The Economist

3. Mon, 10 August 2026

   1 report
   • foreignpolicyjournal.com00:24
     Eli Lilly (NYSE: LLY) Files For Next-Gen Weight-Loss Drug Retatrutide In Q1 2027, Leaving Novo Nordisk (NYSE: NVO) Scrambling

     Eli Lilly (NYSE: LLY) has officially confirmed it will submit a Biologics License Application to the U.S. Food and Drug Administration for retatrutide in the

4. Tue, 11 August 2026

   1 report
   • bakeryandsnacks.com00:00
     The hunger switch Ozempic doesn’t actually turn off

     A new Yale study challenges what we thought we knew about how Ozempic and other GLP-1 drugs sustain weight loss – here's what the science means for food manufacturers.

5. Wed, 12 August 2026

   1 report
   • The Hill16:19
     Eli Lilly targets alleged black market sales of its experimental GLP-1 drug

     Eli Lilly is suing six entities that it alleges are selling black market versions of its experimental weight-loss drug retatrutide. Lilly's lawsuits target U.S. entities selling illegal retatrutide products, including compounding pharmacies, medical spas and online sellers that sell retatrutide as a weight-loss "hack." Those entities falsely claim their drugs are for “research-use only” when...

6. Thu, 13 August 2026

   2 reports
   • wkbw.com14:41
     GLP-1 drugs are booming in 2026 — here's how to find a safe telehealth provider

     GLP-1 drugs like Ozempic are booming. Experts share red flags and tips for finding a safe telehealth provider.

   • Le Figaro (France)17:23
     Labos européens, américains, chinois… La bataille mondiale des traitements contre l’obésité fait rage

     DÉCRYPTAGE - Ce marché très prometteur, mais aujourd’hui aux mains du duopole Novo Nordisk-Eli Lilly, aiguise les appétits. Les acteurs du monde entier se lancent dans la course.

7. Sat, 15 August 2026

   2 reports
   • Google News - Top Stories02:04
     GLP-1s May Be Working in an Entirely Different Way Than We Thought

     GLP-1s May Be Working in an Entirely Different Way Than We Thought ScienceAlert Scientists solve the mystery of a brain “switch” that can trigger weight loss in opposite ways ScienceDaily New study may change how we think about GLP-1s YaleNews GLP-1 obesity drugs activate hunger neurons to drive fat loss 동아사이언스 New Weight Loss Pills Barely Worked in Mice Until Scientists Uncovered a Brain Circuit Controlling Cravings Medical Daily

   • Index.hr (Croatia)20:17
     "Neuroni gladi" imaju neočekivanu ulogu u djelovanju Ozempica, pokazala studija

     NOVA studija otkriva da Ozempic djeluje i putem "neurona gladi" koji potiču tijelo na aktivnije trošenje masnih zaliha i dugoročno mršavljenje.

8. Sun, 16 August 2026

   1 report
   • derstandard.at16:30
     The brain may be about to have its Ozempic moment

     Pharma’s newest obsession involves mimicking the system that keeps people awake

9. Mon, 17 August 2026

   1 report
   • news24.com15:24
     Nestlé plans new products to manage ‘Ozempic face’ and other weight loss side effects

     Nestlé is looking to turn the rise of GLP-1 weight loss drugs from a threat into a business opportunity, using AI and nutritional science to develop products for millions of consumers taking medicines such as Ozempic and Wegovy.

10. Tue, 18 August 2026

    3 reports
    • confectionerynews.com00:00
      Nestlé bets big on GLP-1s with AI-powered nutrition push

      Nestlé is developing products tailored to GLP-1 users, using AI and nutritional science to address challenges including muscle loss, dehydration and rebound hunger, as the food giant positions itself for the growing weight-loss drug market.

    • foodmanufacture.co.uk00:00
      What do consumers call GLP-1s?

      When consumers talk about GLP-1s, what do they call them? Do they use brand names like Ozempic and Mounjaro, shorthands like 'fat jabs,' or the clinical term itself?

    • fool.com23:10
      Why Amylyx Pharmaceuticals Stock Skyrocketed Today

      GLP-1 drugs aren't just for weight loss.

11. Wed, 19 August 2026

    2 reports
    • El Mundo (Spain)22:13
      El mayor reto de las grandes compañías alimentarias: la gente que ya no quiere comer

      Con los fármacos GLP-1 amenazando miles de millones de dólares en ventas, los fabricantes de alimentos envasados están probando formas de ganarse a quienes ya no tienen tanto apetito Leer

    • El Mundo (Spain)22:16edited after publishing
      El fenómeno de la berberina: ¿realmente funciona como un Ozempic natural o hay exageración?

      previously¿Es exagerado llamar a la berberina el Ozempic natural?

      Es uno de los suplementos más respaldados por la ciencia para el control glucémico pero, ¿realmente la berberina funciona como un medicamento análogo de GLP-1 o hay exageración y mucho marketing? Leer

12. Thu, 20 August 2026

    4 reports
    • Google News - Top Stories12:53
      Wegovy and Zepbound are changing how Americans get health care

      Wegovy and Zepbound are changing how Americans get health care USA Today GLP-1s are forcing a strategic reset across healthcare: Wells Fargo report Fierce Healthcare Researchers find new benefits, risks in GLP-1 weight loss drugs WAFB How GLP-1 weight loss drugs are reshaping the healthcare industry Fox Business Scientists Are Discovering Unexpected Benefits of GLP-1 Drugs SciTechDaily

    • Google News - Top Stories13:05
      How GLP-1 weight loss drugs are reshaping the healthcare industry

      How GLP-1 weight loss drugs are reshaping the healthcare industry Fox Business Wegovy and Zepbound are changing how Americans get health care USA Today Researchers find new benefits, risks in GLP-1 weight loss drugs WAFB Scientists Are Discovering Unexpected Benefits of GLP-1 Drugs SciTechDaily Beyond GLP-1s: Combination Therapy, New Hormones Reshape Obesity Treatment Yale Medicine

    • yahoo.com21:05
      There’s a Black Market for Eli Lilly’s Unapproved GLP-1 Drug. Here’s Why That’s Bullish

      Can anyone challenge Eli Lilly in the weight loss space?

    • ABC (Spain)22:45edited after publishing
      La pastilla que adelgaza e imita los beneficios del ejercicio

      previouslyPost-Ozempic: una pastilla que adelgaza e imita los beneficios del ejercicio

      Durante décadas, adelgazar con un tratamiento parecía más una promesa que una realidad, casi como la ilusión que se vendía con las cremas antiedad. Hasta que llegaron Ozempic y otros medicamentos de la familia GLP-1. El mundo ahora se divide entre los que pierden peso con un pinchazo y los que siguen esforzándose con dieta y ejercicio. Pero si conoce a alguien en tratamiento, sabrá que perder peso con estos fármacos tampoco es tan sencillo. Muchos abandonan la medicación por sus efectos...

13. Fri, 21 August 2026

    2 reports
    • Times of India04:57edited after publishing
      Lip plumpers, collagen & more: How Ozempic is boosting a new beauty market

      previouslyLip plumpers, collagen and more: How is Ozempic boosting a new beauty market

      Weight-loss drugs are creating new demands in beauty and nutrition sectors. Companies are developing products to address nutritional gaps and emerging beauty concerns. Nestle and Tata Consumer are preparing protein and fiber-rich offerings for these consumers. Beauty brands are promoting makeup alternatives to cosmetic procedures for users. This trend is driven by pharmaceutical advancements and growing patient bases.

    • wxyz.com15:03
      Researchers test GLP-1 medications as possible treatment for opioid addiction

      Vanderbilt researchers are studying whether GLP-1 drugs used for diabetes and obesity can help prevent opioid relapse.

      2 reprints

      • wkbw.com21 Aug, 15:03their copy
      • katc.com21 Aug, 15:03their copy
14. Sat, 22 August 2026

    1 report
    • El País (Spain)03:30
      La personalidad Ozempic o cómo la delgadez extrema acaba con el placer: “Me arrebató mi habitual optimismo”

      Usuarios de medicamentos GLP-1 se sinceran en las redes sobre su anhedonia, un efecto secundario que les impide disfrutar o interesarse por las actividades que antes les resultaban gratificantes

15. Sun, 23 August 2026

    3 reports
    • DW Top Stories09:20
      Is the US seeing a turning point in obesity rates?

      Obesity rates climbed in the US for years, but now there are signs this could be changing. Use of weight-loss drugs such as Ozempic and Wegovy has increased rapidly — are they helping?

    • juneauempire.com15:30
      MY TURN: The biological prescription schools are ignoring

      In the ongoing debate surrounding America’s metabolic crisis, we have reached a bizarre cultural paradox. On one side, we are witnessing the medicalization of appetite: millions of adults are turning to GLP-1 receptor agonists like Ozempic and Wegovy to synthetically force their bodies into feeling full. On the other, public health dialogue remains stubbornly fixated on lecturing individuals about willpower.

    • sbs.com.au19:48edited after publishing
      The hidden underbelly of Australia's weight-loss drug boom

      Below the surface of Australia's weight-loss drug boom, a market operates outside the prescription system.

16. Mon, 24 August 2026

    6 reports
    • sci.news17:31
      Researchers Revive Decades-Old Drug to Fight Obesity

      Scientists have identified a decades-old chemical compound as a promising new candidate for treating obesity and related metabolic diseases.

    • The Hill18:53
      Unexpected GLP-1 side effect? Studies show the meds may help people with addictions

      From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs, which have proven effective in treating obesity and diabetes, may also be useful in treating addiction.

    • iheart.com20:04
      GLP-1 Medications Could Treat Addiction

      GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.

    • iheart.com20:04
      GLP-1 Medications Could Treat Addiction

      GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.

    • iheart.com20:04
      GLP-1 Medications Could Treat Addiction

      GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.

    • iheart.com20:04
      GLP-1 Medications Could Treat Addiction

      GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.

17. Tue, 25 August 2026

    5 reports
    • mykisscountry937.com09:19
      Doctors Confirm: Unplanned Side Effects When You Take GLP-1 Meds

      Several unpublished but very beneficial side effects appear to be connected to the use of those medications.

    • foxnews.com10:00
      GLP-1 boom could reshape restaurant bars as diners cut back on alcohol

      A new report reveals a growing interest in drink choices among restaurant customers. The report found that health is already influencing some Americans' decisions about alcohol.

    • Index.hr (Croatia)13:35
      Psilijum je novi hit za mršavljenje, no može li doista zamijeniti Ozempic?

      POPULARNOST lijekova za mršavljenje potaknula je potragu za jeftinijim i lako dostupnim alternativama.

    • fool.com19:18
      2 Stocks That Could Capitalize on the GLP-1 Boom

      They aren't the most prominent names in the GLP-1 space, but they are worth a second look.

    • fool.com19:18
      2 Stocks That Could Capitalize on the GLP-1 Boom

      They aren't the most prominent names in the GLP-1 space, but they are worth a second look.

18. Fri, 28 August 2026

    3 reports
    • aol.com11:00
      You'll Never Believe Where Weight Goes When You Lose It

      This is certainly enlightening.

    • Google News - Top Stories18:38
      US FDA approves Lilly's Mounjaro to reduce cardiovascular risk

      US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters Mounjaro Is Now Approved to Lower the Risk of Heart Events Time Magazine FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes Eli Lilly and Company Lilly Diabetes Shot Mounjaro Wins US Approval for Heart Disease Bloomberg.com Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients Fierce Pharma

    • time.com18:56
      Mounjaro Is Now Approved to Lower the Risk of Heart Events

      The new indication for Eli Lilly's drug is for people with Type 2 diabetes.

19. Sun, 30 August 2026

    2 reports
    • bworldonline.com16:04
      Beyond the scale: US men turn to cosmetic clinics to complete weight-loss transformation

      AS TOP-SELLING weight-loss drugs help more US men slim down, a growing number are seeking cosmetic treatments for sagging skin, hair loss, and dental issues to complete their physical transformation, patients and plastic surgeons say. Mark C., a 57-year-old from Hoboken, New Jersey, has spent the past five years taking obesity medications, first Novo Nordisk’s […]

    • edenmagnet.com.au20:00
      Weight drugs trigger 'cultural body trauma' for women

      The rise of GLP-1 medications for weight loss might have triggered another "cultural trauma" about women's bodies and...

      1 reprint

      • bluemountainsgazette.com.au30 Aug, 20:00their copy
20. Mon, 31 August 2026

    5 reports
    • ABC News (Australia)02:12
      GLP-1 drug prescribed to woman with eating disorder via telehealth

      The ABC has learned of a young woman with anorexia nervosa who was prescribed an Ozempic-like drug through a telehealth clinic. Experts say the incident highlights the need for more oversight.

    • forbes.com08:30
      Together, GLP-1s And GenAI Can Solve Healthcare’s Affordability Crisis

      Two innovations offer a new path to healthcare affordability: GLP-1 medications and generative AI. Here's how to two could radically improve medicine and lower costs.

    • theguardian.com12:00
      ‘Who knows what they’re taking?’: people risk the gray market for the newest weight-loss drug

      Retatrutide, not yet approved by the FDA, is the latest wonder drug to shed pounds despite warnings from doctors

    • Google News - Top Stories22:32
      GLP-1 weight loss drugs effective even at low starter doses

      GLP-1 weight loss drugs effective even at low starter doses Reuters Inappropriate use of GLP-1-based antiobesity medications: beyond appropriate drug use toward appropriate weight reduction | Diabetology International Springer Nature Link GLP-1 RAs produce significant weight loss in adults without diabetes, with newer treatments showing greater results Medical Xpress GLP-1s may have a host of other health benefits. Just ask these people usatoday.com Experts call for safer weight loss as...

    • yahoo.com22:43
      GLP-1s may work by activating an unlikely weight loss ally

      A neuron known for stimulating hunger is actually triggered into overdrive by semaglutide.

21. Tue, 1 September 2026

    4 reports
    • vendingmarketwatch.com00:00edited after publishing
      GLP-1 users shift toward protein-rich snacks and smaller meals

      previouslyGLP-1 food trends reshape snacking and small meal choices

    • Tagesschau (Germany)08:40
      Neue US-Studie: Verursachen Abnehmspritzen Haarausfall?

      Viele Diabetes-Medikamente werden auch bei starkem Übergewicht eingesetzt. Eine US-Studie zeigt nun: Bei GLP-1-Mitteln ist das Risiko für Haarausfall höher als bei anderen Medikamenten. Von Doris Tromballa.

    • The Hill10:10
      GLP-1s may work by activating an unlikely weight loss ally

      Unfortunately, testing hunger neurons in a living person isn't possible, but the study's authors hope their data can guide researchers toward new weight loss treatments.

    • El Mundo (Spain)20:42
      Ozempic ya se usa para tratar a adictos en España: "Bebía tres botellas por noche, ahora me vale con dos copas"

      Fernando estaba tan enganchado que llegó a caerse de un tercer piso y, aun así, siguió bebiendo. Ahora, un pinchazo semanal de un GLP-1 le ayuda a moderar su consumo. Es el primer español que cuenta su tratamiento de adicción con este fármaco, un abordaje que divide a los especialistas Leer

22. Wed, 2 September 2026

    4 reports
    • Il Fatto Quotidiano (Italy)11:50
      Boom di acquisti di farmaci dimagranti, l’allarme degli esperti: “Non sono una scorciatoia estetica, hanno effetti molto potenti ecco cosa si rischia ad usarli senza una diagnosi”

      Semaglutide e Tirzepatide stanno cambiando profondamente il trattamento del diabete di tipo 2 e dell’obesità. Ma proprio il loro successo terapeutico sta creando un equivoco: considerarli semplicemente come “farmaci dimagranti”. In realtà, quando vengono prescritti a un paziente con diabete o con obesità clinicamente significativa, siamo di fronte a terapie farmacologiche per patologie croniche, con […] L'articolo Boom di acquisti di farmaci dimagranti, l’allarme degli esperti: “Non sono una...

    • endocrinologyadvisor.com13:26
      GLP-1 Use Not Linked to Low Cup-to-Disc Ratio in Nonarteritic Optic Neuropathy

      Low cup-to-disc ratio is common in fellow eyes of patients with nonarteritic anterior ischemic optic neuropathy, regardless of GLP-1 RA use.

    • endocrinologyadvisor.com13:29
      Obesity Is Associated With Poorer Clinical Outcomes in Primary Aldosteronism

      For patients with obesity and primary aldosteronism, there is a link to a higher cardiometabolic burden and poorer clinical response to targeted treatments.

    • womenshealthmag.com15:16
      GLP-1s Are Praised for Silencing Food Noise. That's Not Always a Good Thing, According to Experts

      A dietitian explains what’s at stake.

23. Thu, 3 September 2026

    3 reports
    • Google News - Top Stories09:00
      GLP-1 medications may worsen or speed hair loss in some men, study finds

      GLP-1 medications may worsen or speed hair loss in some men, study finds NBC News Diabetic GLP-1 use linked to increased hair loss risk Penn Today Possible Side Effect for Men on GLP-1s: Baldness Newser Genes May Explain Hair Loss in Men on Wegovy, Ozempic Seoul Economic Daily Fat jabs like Wegovy or Mounjaro can spark hair loss in men, scientists warn The Sun

    • Google News - Top Stories13:04
      Possible Side Effect for Men on GLP-1s: Baldness

      Possible Side Effect for Men on GLP-1s: Baldness Newser Genes May Explain Hair Loss in Men on Wegovy, Ozempic Seoul Economic Daily Some Hair Loss in Men Is Linked to Use of Weight Loss Drugs morningstar.com Why Your Hair Might Be Thinning on a GLP-1 Drug—and What To Do About It Yahoo Health Diabetic GLP-1 use linked to increased hair loss risk Penn Medicine

    • phillyvoice.com20:42
      GLP-1 meds cause more hair loss than other drugs used to treat type 2 diabetes, Penn study finds

      This research provides evidence to a side effect that had been reported anecdotally.

24. Fri, 4 September 2026

    1 report
    • Slobodna Dalmacija (Croatia)11:17
      Popularni lijekovi za mršavljenje nisu za svakoga: poseban oprez nužan je ako imate neki od ovih probavnih problema

      Prije kombiniranja GLP-1 lijekova s postojećim probavnim tegobama važno je uzeti u obzir moguće rizike i nuspojave. GLP-1 lijekovi propisuju se za snižavanje razine šećera u krvi kod osoba s dijabetesom tipa 2, ali i za regulaciju tjelesne težine kod osoba s pretilošću. U ovu skupinu lijekova pripad...

25. Mon, 7 September 2026

    1 report
    • Il Fatto Quotidiano (Italy)11:56
      “Prima era solo un sospetto, ora c’è la conferma. Ozempic, Wegovy e i farmaci dimagranti aumentano la perdita dei capelli, soprattutto negli uomini già predisposti all’alopecia”: il nuovo studio

      Nuova luce su uno dei più temuto effetti collaterali dei nuovi farmaci anti-obesità, i GLP-1 come Ozempic, Wegovy e Zepbound: la perdita dei capelli. Se finora il diradamento della chioma veniva attribuito unicamente al rapido calo ponderale legato all’uso di queste molecole, una ricerca condotta dalla NYU Langone Health dimostra l’esistenza di una vera e […] L'articolo “Prima era solo un sospetto, ora c’è la conferma. Ozempic, Wegovy e i farmaci dimagranti aumentano la perdita dei capelli,...

26. Tue, 8 September 2026

    1 report
    • femalefirst.co.uk12:00
      Weight-loss jabs could cut asthma attacks

      Weight loss jabs could slash the risk of asthma attacks by almost 40 per cent, raising hopes the drugs could offer benefits beyond helping people shed pounds.

27. Wed, 9 September 2026

    2 reports
    • Google News - Top Stories11:00
      Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study

      Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study Fox News

    • Google News - Top Stories16:10
      Scientists Found a Surprising Effect of Ozempic. It Involves Your Lungs

      Scientists Found a Surprising Effect of Ozempic. It Involves Your Lungs Gizmodo Semaglutide Linked To 40% Fewer Asthma Attacks U.S. News & World Report Asthma, COPD Attacks Down With GLP-1 Drugs in the Picture MedPage Today Ozempic and Wegovy linked to nearly 40% fewer asthma attacks Science Daily New study links GLP-1 ingredient to decrease in asthma attacks, COPD flare-ups KSBY News

28. Thu, 10 September 2026

    2 reports
    • Wirtualna Polska (Poland)13:22
      Lek na otyłość wydłuża życie. Efekt większy niż przy ograniczeniu kalorii

      Semaglutyd, popularny lek z grupy analogów GLP-1 stosowany m.in. w cukrzycy typu 2 i otyłości, wydłużał życie starszych myszy i poprawiał ich funkcje poznawcze oraz mięśniowe. Wyniki badania opublikowanego w "Nature" sugerują też korzyści szersze niż te uzyskane wyłącznie przez ograniczenie kalorii w diecie.

    • meddeviceonline.com18:15
      Engineering Medical Devices To Improve Oral Delivery Of Biopharmaceuticals

      Two approved GLP-1 pills validated the demand — and exposed the ceiling that only delivery devices can break.

29. Sun, 13 September 2026

    2 reports
    • Google News - Top Stories17:00
      Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder

      Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder Fox News See more headlines & perspectives on Google News

    • ABC News (Australia)20:01edited after publishing
      Fresh warning after peptide user suffers torn oesophagus

      previouslyPatient suffers torn oesophagus after using unapproved peptide

      The medicines regulator reveals a patient suffered a torn oesophagus after using an unapproved weight-loss peptide labelled as retatrutide.

30. Mon, 14 September 2026

    2 reports
    • The Guardian World02:41
      Peptide user tore oesophagus after using counterfeit product, Australian regulator warns

      TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutide Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast A patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has prompted Australia’s medicines regulator to warn of serious risks of such products. The concern relates to retatrutide, a type of drug known as a...

    • The Hill17:34
      GLP-1-driven vitamin deficiency linked to rare brain disorder: Study

      Researchers found a rare but potentially life-threatening brain disorder in a small number of people taking Ozempic, Wegovy and similar drugs.

31. Tue, 15 September 2026

    2 reports
    • prnewswire.com10:45
      Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health

      Pivotal results from TRIUMPH-2 showed retatrutide, an investigational triple hormone receptor agonist, delivered substantial weight loss and A1C improvements...

    • menshealth.com19:29
      Are GLP-1s the New Statins?

      Cardiologists are working the weight-loss drugs into more patient conversations.

32. Wed, 16 September 2026

    1 report
    • endocrinologyadvisor.com19:18
      FIERCE Pharma 2026: Cultural Stigma, Misinformation May Contribute to Avoidance of GLP-1 RAs

      Cultural stigma and sensationalized media narratives regarding GLP-1 RAs contribute to patient drug avoidance and treatment nonadherence.